FRED B CRAVES
CIK 1014095 · last filed 2025-03-14
FRED B CRAVES is a corporate insider who has filed 61 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MDGL, was dated Mar 14, 2025. Across all open-market trades the lifetime net is −$217.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $174.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$174.09M
5
61
-$217.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Director | 352,779 | $480.77 | $169.61M | -$220.59M | 26 | 2025-03-14 |
| TWST | Director | 58,168 | $76.17 | $4.43M | $0 | 2 | 2019-10-09 |
| DERM | Director | 9,000 | $6.34 | $57.1K | $1.80M | 8 | 2019-06-14 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 635,739 | — | — | $1.00M | 21 | 2011-06-10 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Director | — | — | — | $0 | 1 | 2009-03-16 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-14 | MDGL | Mixed | — | -$3.80M | EDGAR |
| 2024-12-05 | MDGL | Sell (S) | −3,600 | -$1.14M | EDGAR |
| 2024-11-27 | MDGL | Sell (S) | −3,400 | -$1.19M | EDGAR |
| 2024-09-17 | MDGL | Gift (G) | −15,000 | $0 | EDGAR |
| 2024-06-27 | MDGL | Grant (A) | +714 | $0 | EDGAR |
| 2024-06-13 | MDGL | Gift (G) | −84,852 | $0 | EDGAR |
| 2024-05-16 | MDGL | Mixed | — | -$2.47M | EDGAR |
| 2023-12-11 | MDGL | Mixed | −1,560,151 | $0 | EDGAR |
| 2023-06-20 | MDGL | Grant (A) | +1,198 | $0 | EDGAR |
| 2022-06-21 | MDGL | Grant (A) | — | $0 | EDGAR |